Variant report
Variant | esv3400070 |
---|---|
Chromosome Location | chr11:59245677-59259456 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr11:59252103-59252164 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr11:59247412-59247739 | HepG2 | liver: | n/a | chr11:59247562-59247573 |
3 | CEBPB | chr11:59247434-59247639 | A549 | lung: | n/a | chr11:59247562-59247573 |
4 | CEBPB | chr11:59249912-59250088 | IMR90 | lung: | n/a | n/a |
5 | CEBPB | chr11:59249929-59250051 | A549 | lung: | n/a | n/a |
6 | CEBPB | chr11:59247438-59247672 | Hela-S3 | cervix: | n/a | chr11:59247562-59247573 |
7 | CTCF | chr11:59251062-59251130 | GM20000 | blood: | n/a | n/a |
8 | CTCF | chr11:59245613-59245679 | ProgFib | skin: | n/a | n/a |
9 | E2F4 | chr11:59247369-59247649 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | IRF1 | chr11:59258129-59258308 | K562 | blood: | n/a | n/a |
11 | JUN | chr11:59258529-59258534 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | POLR2A | chr11:59247404-59247448 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr11:59258625-59258766 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr11:59250039-59250081 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr11:59245671-59245681 | A549 | lung: | n/a | n/a |
16 | POLR2A | chr11:59249539-59249608 | Gliobla | brain: | n/a | n/a |
17 | STAT3 | chr11:59251550-59251608 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | ZNF274 | chr11:59245968-59246454 | K562 | blood: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:59252907..59254795-chr11:59256449..59259099,2 | K562 | blood: | |
2 | chr11:59252907..59254795-chr11:59256449..59259099,2 | K562 | blood: | |
3 | chr11:59249101..59250760-chr11:59252215..59254490,2 | K562 | blood: | |
4 | chr11:59252180..59254795-chr11:59256449..59259540,4 | K562 | blood: | |
5 | chr11:59249101..59250760-chr11:59252215..59254490,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR4D8P | TF binding region |
ENSG00000204989 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571309353 | chr11:59245699-59245700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73482817 | chr11:59245709-59245710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370928802 | chr11:59245718-59245719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554025037 | chr11:59245791-59245792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373793945 | chr11:59245801-59245802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371754763 | chr11:59245812-59245813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200783661 | chr11:59245838-59245839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372132001 | chr11:59245904-59245905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565882248 | chr11:59245912-59245913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536421433 | chr11:59246011-59246012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371466075 | chr11:59246048-59246049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112625857 | chr11:59246246-59246247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs377410200 | chr11:59246286-59246287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190622286 | chr11:59246302-59246303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183235256 | chr11:59246312-59246313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534371050 | chr11:59246318-59246319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558549853 | chr11:59246368-59246369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186277098 | chr11:59246375-59246376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540719089 | chr11:59246392-59246393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374779831 | chr11:59246408-59246409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560820439 | chr11:59246436-59246437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572685592 | chr11:59246458-59246459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543172594 | chr11:59246519-59246520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551362511 | chr11:59246532-59246533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138635189 | chr11:59246539-59246540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs61419052 | chr11:59246551-59246552 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs537373522 | chr11:59246604-59246605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565077663 | chr11:59246761-59246762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79753364 | chr11:59246803-59246804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530236198 | chr11:59246806-59246807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547502560 | chr11:59246852-59246853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149331052 | chr11:59246892-59246893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190631140 | chr11:59246918-59246919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548374970 | chr11:59246962-59246963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182920712 | chr11:59246969-59246970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537284848 | chr11:59247017-59247018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558685341 | chr11:59247075-59247076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187876476 | chr11:59247096-59247097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs146236163 | chr11:59247103-59247104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534598845 | chr11:59247116-59247117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552710643 | chr11:59247143-59247144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572672453 | chr11:59247159-59247160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573533100 | chr11:59247197-59247198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72923391 | chr11:59247212-59247213 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs555487855 | chr11:59247252-59247253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192871996 | chr11:59247277-59247278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543654569 | chr11:59247316-59247317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572506027 | chr11:59247356-59247357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567036509 | chr11:59247363-59247364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565016294 | chr11:59247417-59247418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:59243400-59246800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr11:59246400-59246800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr11:59246800-59248200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr11:59258000-59258400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |